S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:DCTH

Delcath Systems (DCTH) Stock Price, News & Analysis

$4.77
-0.32 (-6.29%)
(As of 03/28/2024 ET)
Today's Range
$4.76
$5.05
50-Day Range
$3.72
$5.09
52-Week Range
$2.25
$7.99
Volume
393,065 shs
Average Volume
221,309 shs
Market Capitalization
$105.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.50

Delcath Systems MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
287.8% Upside
$18.50 Price Target
Short Interest
Healthy
4.08% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.39mentions of Delcath Systems in the last 14 days
Based on 17 Articles This Week
Insider Trading
Acquiring Shares
$100,001 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.90) to ($1.50) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.48 out of 5 stars

Medical Sector

310th out of 938 stocks

Surgical & Medical Instruments Industry

39th out of 95 stocks

DCTH stock logo

About Delcath Systems Stock (NASDAQ:DCTH)

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

DCTH Stock Price History

DCTH Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Delcath Systems Appoints Martha Rook As COO
DCTH Apr 2024 7.500 call
Delcath Announces $7 Mln Private Placement
See More Headlines
Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/26/2024
Today
3/29/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:DCTH
Employees
52
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.50
High Stock Price Target
$21.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+287.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-36,510,000.00
Net Margins
-2,308.86%
Pretax Margin
-2,079.17%

Debt

Sales & Book Value

Annual Sales
$2.07 million
Book Value
($0.58) per share

Miscellaneous

Free Float
17,394,000
Market Cap
$105.18 million
Optionable
Optionable
Beta
0.51
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

DCTH Stock Analysis - Frequently Asked Questions

Should I buy or sell Delcath Systems stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCTH shares.
View DCTH analyst ratings
or view top-rated stocks.

What is Delcath Systems' stock price target for 2024?

4 Wall Street analysts have issued 1-year target prices for Delcath Systems' shares. Their DCTH share price targets range from $13.00 to $21.00. On average, they anticipate the company's share price to reach $18.50 in the next year. This suggests a possible upside of 287.8% from the stock's current price.
View analysts price targets for DCTH
or view top-rated stocks among Wall Street analysts.

How have DCTH shares performed in 2024?

Delcath Systems' stock was trading at $4.16 at the beginning of 2024. Since then, DCTH stock has increased by 14.7% and is now trading at $4.77.
View the best growth stocks for 2024 here
.

Are investors shorting Delcath Systems?

Delcath Systems saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 898,900 shares, an increase of 8.0% from the February 29th total of 832,700 shares. Based on an average daily trading volume, of 235,400 shares, the short-interest ratio is currently 3.8 days.
View Delcath Systems' Short Interest
.

When is Delcath Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our DCTH earnings forecast
.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) issued its earnings results on Tuesday, March, 26th. The company reported ($0.48) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $0.19. The firm earned $0.54 million during the quarter, compared to analyst estimates of $0.48 million. Delcath Systems had a negative net margin of 2,308.86% and a negative trailing twelve-month return on equity of 1,007.65%. During the same quarter in the prior year, the business earned ($0.86) EPS.

When did Delcath Systems' stock split?

Delcath Systems shares reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 21st 2019. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Who are Delcath Systems' major shareholders?

Delcath Systems' stock is owned by many different retail and institutional investors. Top institutional investors include AIGH Capital Management LLC (5.36%), Vivo Capital LLC (3.88%), Vanguard Group Inc. (2.37%), Vanguard Group Inc. (2.37%), Worth Venture Partners LLC (1.33%) and ADAR1 Capital Management LLC (1.05%). Insiders that own company stock include Ernest C Garcia II, Gerard J Michel, Gil Aharon, John Purpura, John Richard Sylvester, Rosalind Advisors, Inc, Sandra Pennell, Steven A J Salamon and Vojo Vukovic.
View institutional ownership trends
.

How do I buy shares of Delcath Systems?

Shares of DCTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DCTH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners